Thus, the ability of Ubenimex to reverse the aberrant expression of Pim-3 and other anti-apoptotic proteins in MDR HCC cells may account for its effect in facilitating apoptosis in response to chemotherapeutic drugs. This evidence concerns the gene PIM3 and hepatocellular carcinoma.